First Half 2019 Highlights--
Revenue increased by 42% year-over-year, and 42% organically, to $131.3 million
GAAP income from operations increased 580 bps to 16.9% of revenue
Adjusted (non-GAAP) income from operations increased 870 bps to 27.2% of revenue
GAAP fully-diluted EPS increased to $0.34 compared to $0.14 for the first half of 2018
Adjusted...
RGEN: Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products.
RGEN as a mid-cap is new...
RGEN is showing strong signs of a breakout to new highs. The most interesting point of confirmation for this trade for me is that the RSI resistance line which was established in late June, is now acting as support. Overall the volume is a little low for me to go into a trade, but I might change my mind depending on how strong the confirmation becomes of this breakout.
After forming a double bottom in 2016 this stock has 6-8 months in accumulation forming an ascending triangle pattern with a clear horizontal level of break out. The breakout candle is an outside engulfing day making a convincing looking breakout.
Looking to enter on a pullback into 34 using the low of the breakout day as my stop level.
Target is previous high...
